Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT01192633 | Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma(GVPS) | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Sep 1, 2010 | clinicaltrials |
| NCT00535379 | SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme(SURGE01-07) | unknown | Phase 2 | 70 | Medical University InnsbruckOTHER | 2 | Aug 30, 2010 | clinicaltrials |
| NCT01129154 | Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)(PASCE) | unknown | Phase 2 | 17 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Aug 30, 2010 | clinicaltrials |
| NCT01187290 | Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | unknown | Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 24, 2010 | clinicaltrials |
| NCT01175694 | Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer | unknown | Phase 2 | 200 | University Hospital ErlangenOTHER | 1 | Aug 20, 2010 | clinicaltrials |
| NCT01182272 | Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 36 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01180153 | Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma) | unknown | Phase 2 | 40 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 12, 2010 | clinicaltrials |
| NCT01180504 | Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer(OVAR-IMRT-02) | unknown | Phase 2 | 36 | University Hospital HeidelbergOTHER | 1 | Aug 12, 2010 | clinicaltrials |
| NCT01175096 | Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor | unknown | Phase 1 / Phase 2 | 20 | Guangdong Provincial People's HospitalOTHER | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00363831 | Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 42 | The University of Hong KongOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT01170923 | FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer | unknown | Phase 2 | 100 | Asan Medical CenterOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT01170143 | Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer(PCH) | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00643825 | Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients(PATSGO) | unknown | Phase 2 | 64 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jul 23, 2010 | clinicaltrials |
| NCT01167049 | Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis | unknown | Phase 2 | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jul 22, 2010 | clinicaltrials |
| NCT00561522 | Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection | unknown | Phase 2 / Phase 3 | 290 | Fudan UniversityOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT01166035 | Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors(TEXO) | unknown | Phase 1 / Phase 2 | 20 | Medical University InnsbruckOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00936052 | Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma(HBO) | unknown | Phase 2 | 20 | Neurological Surgery, P.C.OTHER | 1 | Jul 16, 2010 | clinicaltrials |
| NCT00452803 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 102 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00453323 | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | unknown | Phase 2 | 33 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT01158248 | Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer | unknown | Phase 2 | 50 | Medical University InnsbruckOTHER | 1 | Jul 9, 2010 | clinicaltrials |
| NCT01158144 | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) | unknown | Phase 2 | 134 | Zhejiang Cancer HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00563160 | Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery | unknown | Phase 2 | 50 | Hospital Authority, Hong KongOTHER_GOV | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00172159 | Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers | unknown | Phase 2 | 100 | National Taiwan University HospitalOTHER | 1 | Jun 23, 2010 | clinicaltrials |
| NCT00508209 | Bortezomib and High-dose Melphalan at Myeloma Relapse | unknown | Phase 2 | 50 | Nordic Myeloma Study GroupOTHER | 3 | Jun 22, 2010 | clinicaltrials |
| NCT01146977 | Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)(CBF(+)AML) | unknown | Phase 2 | 43 | Cooperative Study Group A for HematologyNETWORK | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01148173 | High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas | unknown | Phase 2 | 30 | Charite University, Berlin, GermanyOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01145924 | Transbronchial Needle Forceps for Endobronchial Ultrasound | unknown | Phase 2 | 50 | Heidelberg UniversityOTHER | 1 | Jun 17, 2010 | clinicaltrials |
| NCT01142713 | The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study | unknown | Phase 2 | 30 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00868478 | The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) | unknown | Phase 1 / Phase 2 | 15 | Kaplan Medical CenterOTHER | 1 | Jun 2, 2010 | clinicaltrials |
| NCT01132989 | Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma(REvMM2009) | unknown | Phase 2 | 10 | Florida Academic Dermatology CentersOTHER | 1 | May 28, 2010 | clinicaltrials |
| NCT01131429 | A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | May 27, 2010 | clinicaltrials |
| NCT00153569 | Multiepitope Peptide Vaccination in Melanoma | unknown | Phase 2 | 25 | Charite University, Berlin, GermanyOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00343668 | S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer | unknown | Phase 2 | 44 | Korean Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01130779 | The Continuation of Erlotinib | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01091376 | Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)(RT0901) | unknown | Phase 2 | 75 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00805636 | Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. | unknown | Phase 2 | 30 | Aposense Ltd.INDUSTRY | 1 | May 12, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00178802 | Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers | unknown | Phase 2 | 24 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 23, 2010 | clinicaltrials |
| NCT01090505 | Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 160 | Chinese PLA General HospitalOTHER | 1 | Mar 22, 2010 | clinicaltrials |
| NCT01083719 | A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes. | unknown | Phase 2 | 15 | Medanta Institute of Clinical ResearchOTHER | 0 | Mar 10, 2010 | clinicaltrials |
| NCT01073683 | Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer | unknown | Phase 2 | 100 | Rabin Medical CenterOTHER | 1 | Mar 5, 2010 | clinicaltrials |
| NCT00690300 | Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer | unknown | Phase 2 | 44 | University of UlmOTHER | 1 | Mar 3, 2010 | clinicaltrials |
| NCT00633165 | Brostallicin Clinical Trial for Myxoid Liposarcoma(SMI-BRS-202) | unknown | Phase 2 | 24 | Systems Medicine LLCINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00707681 | Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) | unknown | Phase 2 | 60 | Microbio Co LtdINDUSTRY | 1 | Feb 26, 2010 | clinicaltrials |
| NCT00948337 | A Study With Health Educational Material on Health Promotion in Cancer Survivors | unknown | Phase 2 | 326 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 26, 2010 | clinicaltrials |
| NCT01066429 | DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma | unknown | Phase 2 | 30 | Hospital Universitario Principe de AsturiasOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00914017 | Statins and Breast Cancer Biomarkers | unknown | Phase 2 | 100 | University of VermontOTHER | 1 | Feb 11, 2010 | clinicaltrials |
| NCT00991250 | SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma | unknown | Phase 2 | 140 | SentoClone ABINDUSTRY | 1 | Feb 5, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Sep 2, 2010source: clinicaltrials